About this trial
The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE.
The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings.
The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.
Eligibility criteria
Qualifiers
Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting.
Disqualifiers
Children (age under 18 years)
Vulnerable populations
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of Pennsylvania
Lead sponsor
Weill Medical College of Cornell University
Sponsor institution
Weill Medical College of Cornell University
Collaborator